Initial cost of primary angioplasty for acute myocardial infarction

Journal of the American College of Cardiology

Volumn 28, Issue 4, 1996, Pages 882-889

  Lieu, Tracy A ^a   Lundstrom, Robert J ^a   Ray, G Thomas ^a   Fireman, Bruce H ^a   Gurley, R Jan ^b   Parmley, William W ^c  

^a DIVISION OF RESEARCH   (United States)

^b S Francisco Dept of Public Health   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH CARE POLICY; HEART CATHETERIZATION; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; UNITED STATES;

EID: 0030273299     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00237-9     Document Type: Article

References (34)

1. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI). GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 1990;336:65-71.
2. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;335:349-60.
3. Grines CL, Brown KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-9.
4. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993;328:685-91.
5. Zijlstra F, de Boer MJ, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-4.
6. Aguirre FV. The cost of an open infarct-related artery: comparison of treatment modalities in the reperfusion era. Mayo Clin Proc 1994;69:87-9.
7. 1993 Drug Topics Red Book. Montvale (NJ): Medical Economics Data, 1993.
8. Reeder GS, Bailey KR, Gersh BJ, Holmes DR, Christianson J, Gibbons RJ Cost comparison of immediate angioplasty versus thrombolysis followed by conservative therapy for acute myocardial infarction: a randomized prospective trial. Mayo Clin Proc. 69:1994;5-12.
9. de Boer MJ, van Hout BA, Liem AL, Suryapranata H, Hoorntje JCA, Zijlstra F. Cost-effectiveness analysis of primary coronary angioplasty vs. thrombolysis for acute myocardial infarction. Am J Cardiol 1995:76:830-2.
10. American Hospital Association Hospital Statistics, 1993-94 Edition. Chicago: American Hospital Association, 1993:206-7;218-9.
11. Hlatky MA, Lipscomb J, Nelson C, et al. Resource use and cost of initial coronary revascularization. Coronary angioplasty versus coronary bypass surgery. Circulation 1990;82 Suppl IV:IV-208-13.
12. McClellan M, McNeill BJ, Newhouse JP. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA 1994;272:859-66.
13. Rogers WJ, Bowlby LJ, Chandra NC, et al. Treatment of myocardial infarction in the United States (1990 to 1993). Circulation 1994;90:2103-14.
14. Goldberg RJ, Gore JM, Alpert J, et al. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med 1991;325:1117-22.
15. Althouse R, Maynard C, Cerqueira MD, Olsufka M, Ritchie JL, Kennedy JW. The Western Washington myocardial infarction registry and emergency department tissue plasminogen activator treatment trial. Am J Cardiol 1990;66:1298-303.
16. Krumholz HM, Friesinger GC, Cook EF, Lee TH, Rouan GW, Goldman L. Relationship of age with eligibility for thrombolytic therapy and mortality among patients with suspected acute myocardial infarction. J Am Geriatr Soc 1994;42:127-31.
17. Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985;313:1315-22.
18. Thompson DR, Sutton TW, Jowett NI, Pohl JE. Circadian variation in the frequency of onset of chest pain in acute myocardial infarction. Br Heart J 1991;65:177-8.
19. Krumholz HM, Pasternak RC, Weinstein MCet al. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction. N Engl J Med. 327:1992;7-13.
20. Keeler EB, Cretin S. Discounting of life-saving and other nonmonetary effects. Management Sci 1983;29:300-6.
21. de Jaeger PP, Simoons ML. Immediate angioplasty: a conservative view from Europe. Br Heart J 1995;73:407-8.
22. Boyle RM. Immediate angioplasty in the United Kingdom. Br Heart J 1995;73:413-4.
23. Rogers WJ, Dean LS, Moore PB, et al. Comparison of primary angioplasty versus thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1994;74:111-8.
24. Goldman L. Cost and quality of life: thrombolysis and primary angioplasty. J Am Coll Cardiol. 25(Suppl):1995;38S-41S.
25. de Boer MJ, van Hout BA, Liem AL, Suryapranata H, Hoorntje JCA, Zijlstra F. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction. Am J Cardiol 1995;76:830-3.
26. Mark DB, O'Neill WW, Brodie B, et al. Baseline and 6-month costs of primary angioplasty therapy for acute myocardial infarction: results from the Primary Angioplasty Registry. J Am Coll Cardiol 1995;26:688-95.
27. Stone GW, Grimes CL, Browne KF, et al. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) Trial. J Am Coll Cardiol 1995;25:370-7.
28. Reeder GS, Krishan I, Nobrega FT, et al. Is percutaneous coronary angioplasty less expensive than bypass surgery? N Engl J Med 1984;311:1157-62.
29. Ritchie JL, Phillips KA, Luft HS. Coronary angioplasty: statewide experience in California. Circulation 1993;88:2735-43.
30. Jollis JG, Peterson ED, DeLong ER, et al. The relation between the volume of coronary angioplasty procedures at hospitals treating Medicare beneficiaries and short-term mortality. N Engl J Med 1994;331:1625-9.
31. Kimmel SE, Berlin JA, Laskey WK. The relationship between coronary angioplasty procedure volume and major complications. JAMA 1995;274:1137-42.
32. Meier B, Urban P, Dorsaz PA, Favre J. Surgical standby for coronary balloon angioplasty. JAMA 1992;268:741-5.
33. Ryan TJ, Bauman WB, Kennedy JW, et al. Guidelines for percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1993;22:2033-54.
34. Mark DB, Hlatky MA, Califf RM, et al. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med 1995;332:1418-24.